|
End-of-day quote
Other stock markets
|
||
| - | - |
|
| Manager | Title | Age | Since |
|---|---|---|---|
Andrew Nash
CEO | Chief Executive Officer | - | - |
Andrew Boyd
DFI | Director of Finance/CFO | - | 2011-02-28 |
| Corporate Officer/Principal | - | 2011-02-28 |
| Director | Title | Age | Since |
|---|---|---|---|
Andrew Nash
BRD | Director/Board Member | - | 2011-02-28 |
Brian McNamee
BRD | Director/Board Member | 70 | - |
Antoni M. Cipa
BRD | Director/Board Member | - | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +4.73% | +3.38% | +19.53% | -8.89% | 66.56B | |
| -1.93% | +0.39% | +58.62% | +226.33% | 57.64B | |
| +1.07% | +42.10% | +42.10% | +42.10% | 42.24B | |
| +3.45% | +6.04% | -49.46% | -55.91% | 39.09B | |
| +3.04% | +0.04% | +62.66% | -24.29% | 31.91B | |
| +10.01% | +18.57% | +161.59% | -34.48% | 31.65B | |
| +2.68% | +2.73% | +70.72% | +88.24% | 23.35B | |
| +2.87% | +16.83% | +3.78% | +192.67% | 18.92B | |
| -0.13% | +2.75% | +67.48% | +130.07% | 17.17B | |
| Average | +2.87% | +7.50% | +48.56% | +61.76% | 36.5B | |
| Weighted average by Cap. | +2.78% | +6.28% | +44.19% | +55.15% |
Employees
-
Sector
Pharmaceuticals
- Stock Market
- Stocks
- ZTL Stock
Select your edition
All financial news and data tailored to specific country editions
